Obesity Drugmaker Escapes Clinical Trial Securities Suit
By Sydney Price · October 31, 2025, 4:55 PM EDT
Biopharmaceutical company BioAge Labs Inc. has, for now, escaped a suit alleging investors were hurt by plummeting share prices after the company unexpectedly halted a clinical trial for a weight loss...
To view the full article, register now.